News
Life sciences
Michelle Carnahan appointed as board member at Oviva
22. November 2024
Oviva has appointed Michelle Carnahan as a new member of its Board of Directors. The president of Thirty Madison will call on her expertise to drive innovation at the healthcare company.
Read more
Dividat acquires new customers in the U.S.
16. October 2024
Dividat Senso has been installed in three more rehabilitation and care facilities in the U.S. The training device developed by Dividat, a medtech company based in the Swiss canton of Schwyz, specifically promotes physical-cognitive interplay. It can
Read more
Boehringer Ingelheim acquires Saiba Animal Health
04. September 2024
Boehringer Ingelheim has completed an acquisition of Saiba Animal Health. The innovative technology platform developed by Saiba Animal Health, which is based in the Greater Zurich Area, will give the German pharma company more options for developing
Read more
American scientific journal publishes study results on Octapharma drug
15. August 2024
Study results on the efficacy and safety of the drug Balfaxar, developed by Octapharma from Lachen in the Swiss canton of Schwyz, have been published by the JAMA Network Open. The journal is published by the American Medical Association.
Read more
FDA expands approval for Octapharma bleeding control solution
02. August 2024
The US FDA has expanded the approval of the bleeding control solution Fibryga. Developed by Octapharma, the solutions can now also be used for bleeding patients with acquired fibrinogen deficiency.
Read more
Oviva Direkt recognized on the German healthcare market
30. July 2024
The health app Oviva Direkt has been designated as a digital health application (DiGA) in Germany. The app can be used to prevent and treat obesity.
Read more
Dividat focuses on living better for longer
24. July 2024
Dividat is inviting interested parties to the Think & Move Symposium at the Swiss art museum Kunsthaus Zürich on September 3. It focuses on the art of living better for longer. The program comprises lectures, case examples, and a podium discussion.
Read more
Octapharma presents latest studies at Bangkok conference
26. June 2024
Octapharma, based in the Swiss canton of Schwyz, is presenting new clinical and scientific findings on its medicines targeting rare bleeding disorders at the ISTH 2024 Congress in Bangkok. The conference is taking place from June 22 to 26. The
Read more
Physio Herzog uses Dividat Senso platform
26. June 2024
The Physio Herzog treatment center is using Dividat Senso. The training platform produced by Dividat, a company based in Schindellegi in the Swiss canton of Schwyz, helps improve physical and cognitive abilities.
Read more
Medlake Training now using the Dividat Senso
24. May 2024
Medlake Training is joining forces with Dividat. The competence center for health-focused strength and endurance training is now using the Dividat Senso to promote cognitive and motor performance.
Read more
Oviva is one of the world’s best HealthTech companies
25. April 2024
Oviva, a digital HealthTech company from the canton of Schwyz, has been named in the World's Best Digital Health Companies 2024. This is the first time that Newsweek magazine and the German online platform Statista have compiled a list of the 400
Read more
Octapharma increases sales by 14.4 per cent
23. February 2024
Octapharma from the canton of Schwyz increased its turnover by 14.4 per cent to a new record of 3.266 billion euros in 2023. This growth was driven by a significant increase in plasma collection and continuing strong demand.
Read more